187 related articles for article (PubMed ID: 31673232)
1. Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics.
Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF
Int J Med Sci; 2019; 16(11):1424-1429. PubMed ID: 31673232
[TBL] [Abstract][Full Text] [Related]
2. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
Tang Y; Wang Y; Wang X; Liu Y; Zheng K
Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
[TBL] [Abstract][Full Text] [Related]
3. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke.
Zheng Z; Liu S; Wang C; Han X
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3535-3541. PubMed ID: 30197169
[TBL] [Abstract][Full Text] [Related]
4. Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis.
Shen Z; She Q
Cell Physiol Biochem; 2018; 49(4):1431-1443. PubMed ID: 30205366
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer.
Li Q; Ma G; Sun S; Xu Y; Wang B
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):478-482. PubMed ID: 29602737
[TBL] [Abstract][Full Text] [Related]
6. The Variant rs145204276 of GAS5 is Associated with the Development and Prognosis of Gastric Cancer.
Li QJ; Ma G; Guo HM; Sun SH; Xu Y; Wang BJ
J Gastrointestin Liver Dis; 2018 Mar; 27(1):19-24. PubMed ID: 29557411
[TBL] [Abstract][Full Text] [Related]
7. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer.
Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471
[TBL] [Abstract][Full Text] [Related]
8. The relationships of genetic polymorphisms of the long noncoding RNA growth arrest-specific transcript 5 with uterine cervical cancer.
Weng SL; Ng SC; Lee YC; Hsiao YH; Hsu CF; Yang SF; Wang PH
Int J Med Sci; 2020; 17(9):1187-1195. PubMed ID: 32547314
[TBL] [Abstract][Full Text] [Related]
9. Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients.
Hsieh MH; Wu YL; Tsao TC; Huang YW; Lin JC; Lee CY; Hsieh MJ; Yang SF
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011604
[TBL] [Abstract][Full Text] [Related]
10. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A.
Yuan J; Zhang N; Zheng Y; Chen YD; Liu J; Yang M
DNA Cell Biol; 2018 Sep; 37(9):750-757. PubMed ID: 30074406
[TBL] [Abstract][Full Text] [Related]
11. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer.
Zheng Y; Song D; Xiao K; Yang C; Ding Y; Deng W; Tong S
Oncotarget; 2016 Dec; 7(50):83727-83734. PubMed ID: 27863421
[TBL] [Abstract][Full Text] [Related]
12. Rs145204276 and rs4759314 affect the prognosis of prostate cancer by modulating the GAS5/miR-1284/HMGB1 and HOTAIR/miR-22/HMGB1 signalling pathways.
Deng ZH; Yu GS; Pan B; Feng ZH; Huang Q; Deng JZ; Chen B; Yang SK
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):435-442. PubMed ID: 31916466
[TBL] [Abstract][Full Text] [Related]
13. Growth arrest-specific 5 (GAS5) insertion/deletion polymorphism and cancer susceptibility in Asian populations: A meta-analysis.
Gao G; Liu C; Li X; Guan X; Yang X; Qin P
Medicine (Baltimore); 2021 Oct; 100(41):e27415. PubMed ID: 34731115
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variants of
Deng F; Zhu P; Liao C; Li S; Hu X; Wang Y; Wu Z; Huang S; Zhong W; Zhao B; Ma G; Li Y
Biomed Res Int; 2021; 2021():6634253. PubMed ID: 33937403
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy.
Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF
Urol Oncol; 2019 Nov; 37(11):814.e9-814.e16. PubMed ID: 31155437
[TBL] [Abstract][Full Text] [Related]
16. A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma.
Xu L; Xia C; Xue B; Sheng F; Xiong J; Wang S
J Bone Oncol; 2018 Sep; 12():23-26. PubMed ID: 30013899
[TBL] [Abstract][Full Text] [Related]
17. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.
Tao R; Hu S; Wang S; Zhou X; Zhang Q; Wang C; Zhao X; Zhou W; Zhang S; Li C; Zhao H; He Y; Zhu S; Xu J; Jiang Y; Li L; Gao Y
Carcinogenesis; 2015 Oct; 36(10):1136-43. PubMed ID: 26163879
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-GAS5 and its Promoter Region Polymorphism Associate with Helper Th17 Polarization and Predict Postoperative Pain and the Prognosis of the Patients with Hepatocellular Carcinoma Undergoing Hepatectomy.
Sha Z; Zhang P
Iran J Immunol; 2022 Dec; 19(4):349-357. PubMed ID: 36585876
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variants of lncRNA
Hsieh MH; Lu HJ; Lin CW; Lee CY; Yang SJ; Wu PH; Chen MK; Yang SF
J Pers Med; 2021 Apr; 11(5):. PubMed ID: 33925911
[TBL] [Abstract][Full Text] [Related]
20. Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer risk.
Zhao S; Liu P; Ruan Z; Li J; Zeng S; Zhong M; Tang L
J Int Med Res; 2021 Sep; 49(9):3000605211039798. PubMed ID: 34521242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
